MotherToBaby Launches First Lupus in Pregnancy Research Study
SAN DIEGO, Feb. 1, 2023 /PRNewswire-PRWeb/ -- Recruitment is underway for a groundbreaking new study on the treatment of lupus during pregnancy. The observational research, led by world-renowned UC San Diego epidemiologist Christina Chambers, PhD, MPH, is the first of its kind for the non-profit MotherToBaby, a CDC-recommended organization that provides evidence-based information on medications, diseases, vaccines, herbal supplements and more during pregnancy and breastfeeding.
- SAN DIEGO, Feb. 1, 2023 /PRNewswire-PRWeb/ -- Recruitment is underway for a groundbreaking new study on the treatment of lupus during pregnancy.
- The study will recruit 400 pregnant people over a five-year period to evaluate use of the lupus drug Benlysta® (belimumab) in pregnancy.
- Benlysta® is used to treat the most common type of lupus, systemic lupus erythematosus (SLE), as well as lupus nephritis.
- The study will be MotherToBaby's first to focus on a treatment specifically for lupus, and participants will be enrolled into the MotherToBaby Pregnancy Studies research program.